Earnings Per Share - Potential Common Stock Equivalents Excluded from Calculation of Diluted Net Income Per Share (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive securities (in shares) | 24,001,219 | 13,841,294 |
| Restricted stock units | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive securities (in shares) | 14,134,205 | 13,614,370 |
| CEO Premium-Priced Performance Option | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive securities (in shares) | 9,678,000 | 0 |
| Exercise of common stock options | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total anti-dilutive securities (in shares) | 189,014 | 226,924 |